1-2 of 2
Hester A. de Groot-Kruseman
Close
Sort by
Journal Articles

Optimized cytogenetic risk-group stratification of KMT2A -rearranged pediatric acute myeloid leukemia

Romy E. van Weelderen, Christine J. Harrison, Kim Klein, Yilin Jiang, Jonas Abrahamsson, Todd Alonzo, Richard Aplenc, Nira Arad-Cohen, Emmanuelle Bart-Delabesse, Barbara Buldini, Barbara De Moerloose, Michael N. Dworzak, Sarah Elitzur, José M. Fernández Navarro, Alan Gamis, Robert B. Gerbing, Bianca F. Goemans, Hester A. de Groot-Kruseman, Erin Guest, Shau-Yin Ha, Henrik Hasle, Charikleia Kelaidi, Hélène Lapillonne, Guy Leverger, Franco Locatelli, Takako Miyamura, Ulrika Norén-Nyström, Sophia Polychronopoulou, Mareike Rasche, Jeffrey E. Rubnitz, Jan Stary, Anne Tierens, Daisuke Tomizawa, C. Michel Zwaan, Gertjan J. L. Kaspers
Journal: Blood Advances
Blood Adv (2024) 8 (12): 3200–3213.
https://doi.org/10.1182/bloodadvances.2023011771
Published: 2024
Includes: Supplemental data
Journal Articles

Tyrosine kinase inhibitor resistance in de novo BCR :: ABL1 –positive BCP-ALL beyond kinase domain mutations

Clinical Trials & Observations
Inge van Outersterp, Judith M. Boer, Cesca van de Ven, Caitlin E. J. Reichert, Aurelie Boeree, Brian Kruisinga, Hester A. de Groot-Kruseman, Gabriele Escherich, Aniko Sijs-Szabo, Anita W. Rijneveld, Monique L. den Boer
Journal: Blood Advances
Blood Adv (2024) 8 (8): 1835–1845.
https://doi.org/10.1182/bloodadvances.2023012162
Published: 2024
Includes: Supplemental data